Arven İlaç

Arven İlaç is a Turkish pharmaceutical company specializing in the development and manufacture of high-tech products, including biosimilars and advanced respiratory delivery systems. As a subsidiary of Toksöz Group, the company operates one of Turkey's most advanced R&D and manufacturing facilities in Kırklareli, which is the first in the country to produce high-tech biosimilars from cell lines. Arven's portfolio focuses on high-value therapeutic areas such as oncology, hematology, and respiratory medicine, utilizing proprietary Dry Powder Inhaler (DPI) technology. The company provides end-to-end services from cell line development to commercial-scale manufacturing, positioning itself as a key player in the regional biopharmaceutical landscape. Arven is committed to increasing the accessibility of complex medicines through domestic production and international partnerships.